Abstract
Assessment of Knowledge and Awareness in Patients Consuming Anti-Gout Drugs in the Region of Roorkee
Author(s): Muzaffar Ali*, Meenakshi Ghildiyal, Paranshu Tangri, Pooja SharmaA typical form of inflammatory arthritis that is treated with anti anti-gout drugs is gout. To maximize therapeutic results and increase patient compliance, it is essential to comprehend patients' awareness and knowledge of these medications. With a particular focus on the Roorkee region, this review paper assesses the body of research on patient knowledge and awareness of anti anti-gout medications. Our goals are to draw attention to areas of unmet need, evaluate how education affects patient outcomes, and offer rec ommendations for improving patient comprehension. Genetic predisposition is playing a more and bigger influence. Acute gouty arthritis, intercritical phase, chronic tophaceous gout, and asymptomatic hyperuricemia compri se the clinical picture of gout. Ra diological and laboratory features are used to make the diagnosis. Diagnosis gold standard: identifying distinctive MSU crystals in the synovial polarized light microscopy on a fluid medium. Conventional radiography, ultrasound, dual dual-energy computed tomogr aphy, conventional CT, magnetic resonance imaging, nuclear scintigraphy, and positron emission tomography are examples of imaging modalities. The use of dualdual-energy CT and ultrasonography has advanced significantly, which will undoubtedly have an impact on clinical research as well as di agnosis, staging, and follow follow-up. Gout management encompasses controlling flare flare-ups, managing chronic gout and preventing flare flare-ups, and managing comorbidities. Newer medications are proving to be effective and serving as a s upplement to older ones in the pharmacological arsenal. A change in food and lifestyle, patient education, and stopping hyperuricemia medications are all crucial aspects of its management.
